4//SEC Filing
Savage William Jacob 4
Accession 0001193125-25-321440
CIK 0001816736other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 9:31 PM ET
Size
8.4 KB
Accession
0001193125-25-321440
Insider Transaction Report
Form 4
Savage William Jacob
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-12-15$90.60/sh−3,642$329,979→ 85,153 total - Sale
Common Stock
2025-12-15$91.44/sh−9,151$836,724→ 76,002 total - Sale
Common Stock
2025-12-15$92.23/sh−300$27,669→ 75,702 total
Footnotes (3)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.02 to $90.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.03 to $91.99, inclusive.
Documents
Issuer
Disc Medicine, Inc.
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001951852
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 9:31 PM ET
- Size
- 8.4 KB